Rachel Goode

Fresenius Kabi USA

SCHOLARLY PAPERS

3

DOWNLOADS

21

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Accelerating Biosimilar Market Access: The Case For Allowing Earlier Standing

WVU College of Law Research Paper Forthcoming, Journal of Law and the Biosciences, volume 12, issue 1, 2025[10.1093/jlb/lsae030]
Number of pages: 16 Posted: 13 Jan 2025
S. Sean Tu, Rachel Goode, Matthew Turner and Victor Van de Wiele
West Virginia University College of Law, Fresenius Kabi USA, Fresenius Kabi USA and University of Cambridge, Faculty of Law
Downloads 21 (1,131,053)

Abstract:

Loading...

patents, medicare, biologic, biosimilar, drug spending

2.

Ancillary Product Patents to Extend Biologic Patent Life

JAMA, Vol. 330(21), p. 2217-2119 (2023), WVU College of Law Research Paper No. 2024-004
Posted: 22 Feb 2024 Last Revised: 01 May 2024
Rachel Goode, William Feldman and S. Sean Tu
Fresenius Kabi USA, Harvard University - Harvard Medical School and West Virginia University College of Law

Abstract:

Loading...

biologic patents, ancillary product patents, trade secret

3.

Biologic Patent Thickets and Terminal Disclaimers

JAMA, Vol. 331(4), p. 335-337 (2023), WVU College of Law Research Paper No. 2024-003
Posted: 22 Feb 2024 Last Revised: 01 May 2024
S. Sean Tu, Rachel Goode and William Feldman
West Virginia University College of Law, Fresenius Kabi USA and Harvard University - Harvard Medical School

Abstract:

Loading...

patent thickets, biosimilar competition, terminal disclaimer, US Patent and Trademark Office, biologic patents